Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate ...
Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical ...